Insider · CIK 0001798876

Car Bruce

Reports to the SEC for 2 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001798876

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-27	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Chief Scientific Officer	AAward	+175K sh	—	—	175,000
2026-01-05	BHVNBiohaven Ltd.F Tax Payment	Chief Scientific Officer	FTax Payment	−2,381 sh	$9.93	−$23.6K	7,715
2026-01-05	BHVNBiohaven Ltd.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,750 sh	—	—	10,096
2026-01-05	BHVNBiohaven Ltd. · Restricted Share Unit AwardM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,750 sh	—	—	9,500
2025-01-05	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Chief Scientific Officer	AAward	+112K sh	—	—	112,000
2025-01-05	BHVNBiohaven Ltd.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,750 sh	—	—	7,133
2025-01-05	BHVNBiohaven Ltd. · Restricted Share Unit AwardM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,750 sh	—	—	14,250
2025-01-05	BHVNBiohaven Ltd. · Restricted Share Unit AwardA Award	Chief Scientific Officer	AAward	+19K sh	—	—	19,000
2025-01-05	BHVNBiohaven Ltd.F Tax Payment	Chief Scientific Officer	FTax Payment	−2,331 sh	$38.64	−$90.1K	4,802
2024-06-17	BHVNBiohaven Ltd.P Purchase	Chief Scientific Officer	PPurchase	+30K sh	$33.58	+$1.01M	30,000
2024-01-02	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Chief Scientific Officer	AAward	+96.3K sh	—	—	96,250
2023-11-02	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Chief Scientific Officer	AAward	+78.8K sh	—	—	78,750
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)A Award	Chief Scientific Officer	AAward	+300K sh	—	—	300,000
2022-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Chief Scientific Officer	AAward	+11.5K sh	—	—	11,500
2022-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Chief Scientific Officer	AAward	+41K sh	—	—	41,000
2022-02-22	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Chief Scientific Officer	FTax Payment	−2,041 sh	$29.08	−$59.4K	16,752
2022-02-18	AGIOAGIOS PHARMACEUTICALS, INC. · Performance share unitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,874 sh	—	—	6,874
2022-02-18	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+6,874 sh	—	—	18,793
2022-02-10	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,667 sh	—	—	12,992
2022-02-10	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,667 sh	—	—	7,333
2022-02-10	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,073 sh	$31.43	−$33.7K	11,919
2022-01-06	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,437 sh	—	—	3,437
2022-01-06	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,437 sh	—	—	10,530
2022-01-06	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,205 sh	$32.58	−$39.3K	9,325
2021-02-10	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Chief Scientific Officer	AAward	+11K sh	—	—	11,000
2021-02-10	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)A Award	Chief Scientific Officer	AAward	+44K sh	—	—	44,000
2021-01-06	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,437 sh	—	—	8,284
2021-01-06	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,191 sh	$44.09	−$52.5K	7,093
2021-01-06	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,437 sh	—	—	6,874
2020-04-14	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Chief Scientific Officer	FTax Payment	−2,027 sh	$40.64	−$82.4K	4,847
2020-04-13	AGIOAGIOS PHARMACEUTICALS, INC. · Performance share unitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,874 sh	—	—	13,748
2020-04-13	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+6,874 sh	—	—	6,874
2020-01-06	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)A Award	Chief Scientific Officer	AAward	+47K sh	—	—	47,007
2020-01-06	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Chief Scientific Officer	AAward	+10.3K sh	—	—	10,311

Recent filings

Accepted (ET)
Mar 34
Car Bruce0001798876-26-000004
SEC(opens sec.gov)
Jan 74
Car Bruce0001798876-26-000002
SEC(opens sec.gov)
Jan 74
Car Bruce0001935979-25-000006
SEC(opens sec.gov)
Jun 204
Car Bruce0001562180-24-005174
SEC(opens sec.gov)
Jan 44
Car Bruce0001562180-24-000286
SEC(opens sec.gov)
Nov 64
Car Bruce0001562180-23-007576
SEC(opens sec.gov)
Oct 54
Car Bruce0001562180-22-007083
SEC(opens sec.gov)
Mar 34
Car Bruce0001439222-22-000030
SEC(opens sec.gov)
Feb 234
Car Bruce0001439222-22-000019
SEC(opens sec.gov)
Feb 144
Car Bruce0001439222-22-000005
SEC(opens sec.gov)

Companies

Address

C/O BIOHAVEN LTD. 215 CHURCH STREET

NEW HAVEN, CT, 06510